Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",49590,300,2.01 [1.40-2.88],0.0001491977785799
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",51383,399,2.24 [1.65-3.05],2.7175243019740093e-07
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",50850,2771,1.98 [1.76-2.23],2.6248236846547164e-29
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Candidiasis,51424,860,2.55 [2.08-3.14],5.503736761976677e-19
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,49869,7029,1.83 [1.69-1.97],6.530634330070123e-54
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),50058,6423,1.89 [1.75-2.05],6.812931800967303e-56
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,50912,2435,1.70 [1.50-1.94],7.897672360672808e-16
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,51235,173,3.16 [2.03-4.93],3.752216243804385e-07
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,47316,1954,2.61 [2.27-2.99],5.444911253622853e-42
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,45712,2218,2.64 [2.31-3.01],6.497283682060796e-48
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,45450,516,3.84 [2.97-4.96],1.1498150989983675e-24
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,36120,3972,2.08 [1.88-2.30],1.945843028273416e-46
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,45144,786,2.69 [2.16-3.36],1.0481895747245704e-18
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,51350,2873,1.78 [1.58-2.00],2.601378345045401e-21
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Mycoses,51580,1016,2.34 [1.93-2.83],4.3044840093389096e-18
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,49941,1862,2.33 [2.02-2.69],7.101528339993963e-31
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,51447,2157,2.43 [2.13-2.77],3.251356128578878e-40
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,48878,401,2.31 [1.70-3.14],9.419044991826997e-08
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,51680,100,3.07 [1.70-5.53],0.0001975198009811
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other septicaemia,51175,1885,2.51 [2.18-2.89],4.112300022730148e-38
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,51218,156,1.56 [0.94-2.61],0.0869321800797873
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other viral diseases,51520,316,2.38 [1.68-3.37],1.0736860952474817e-06
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",51482,278,2.27 [1.56-3.30],1.7619195086872413e-05
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,48922,843,2.27 [1.83-2.81],4.252947438185232e-14
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,48636,557,1.73 [1.32-2.27],6.62099414126645e-05
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,48697,220,2.60 [1.72-3.92],5.335680278791935e-06
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,51637,104,3.07 [1.74-5.42],0.0001057859054219
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,51548,308,1.81 [1.26-2.60],0.001377670910199
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Viral warts,51342,102,1.03 [0.54-1.98],0.9226251088415474
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],51370,130,3.01 [1.77-5.12],4.611676943999279e-05
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign lipomatous neoplasm,51093,590,0.95 [0.73-1.25],0.7309496054095279
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,51504,116,1.06 [0.58-1.97],0.8411098319339047
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,51468,124,0.75 [0.42-1.34],0.329600089483042
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23743,131,0.61 [0.35-1.09],0.0931433061148316
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",51009,2887,1.25 [1.10-1.41],0.0003973148997051
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm of meninges,51651,115,1.00 [0.53-1.86],0.99502167966847
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,51549,131,1.54 [0.88-2.72],0.1317832797445126
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,51632,215,0.97 [0.62-1.52],0.8956885591804685
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm of ovary,27802,180,1.06 [0.64-1.76],0.8221938040641557
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Ascending colon,51633,727,1.38 [1.08-1.75],0.0085845600235176
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Caecum,51634,603,1.15 [0.88-1.50],0.3068507675073989
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",51462,142,0.77 [0.45-1.34],0.3589748845040913
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Descending colon,51628,434,1.31 [0.96-1.78],0.0854985648618558
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Rectum,51549,712,1.25 [0.98-1.60],0.0707964574310137
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,51445,1238,1.18 [0.98-1.42],0.0789479877147792
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Transverse colon,51614,869,1.49 [1.20-1.84],0.0003328328527293
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Carcinoma in situ of breast,22586,140,0.80 [0.44-1.43],0.4452425681638167
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22677,169,1.03 [0.61-1.75],0.9107056467856678
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",41133,105,2.90 [1.61-5.22],0.0003784821427265
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",41166,138,1.68 [0.97-2.92],0.064371219644582
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",51582,241,1.08 [0.70-1.65],0.7384689004095436
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Haemangioma, any site",51583,237,1.03 [0.67-1.59],0.8811047424903143
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Leiomyoma of uterus,26893,593,1.16 [0.88-1.53],0.2987586190005321
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Lung cancer and mesothelioma,35821,656,2.36 [1.89-2.96],6.486576600628939e-14
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Lymphoid leukaemia,41131,103,2.33 [1.26-4.33],0.0070331920030224
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",41403,375,1.08 [0.76-1.52],0.6715172670847833
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",41438,410,1.03 [0.75-1.43],0.8373238743189609
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22813,190,1.01 [0.62-1.65],0.9653977785669158
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",41193,165,4.76 [3.12-7.25],3.9547970065500666e-13
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",41245,217,1.33 [0.86-2.05],0.196314946131447
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",41223,195,2.39 [1.56-3.66],5.830162043337437e-05
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22768,145,1.07 [0.61-1.89],0.8141247177315509
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",41213,185,1.27 [0.79-2.05],0.3294692789101209
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19813,1408,0.97 [0.82-1.16],0.7556630955205832
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",41256,228,1.26 [0.82-1.94],0.2937569859539898
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",41175,147,1.93 [1.16-3.22],0.0113366015935532
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,41240,212,1.88 [1.21-2.92],0.0050794174630655
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Melanocytic naevi,51285,407,1.09 [0.79-1.52],0.5922871284478772
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Melanocytic naevi of trunk,51600,178,1.17 [0.71-1.92],0.5353536894136142
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Melanoma in situ,41097,164,0.67 [0.39-1.14],0.1414064553125077
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",41210,182,1.86 [1.16-2.99],0.0101227809603439
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",41351,323,1.70 [1.19-2.44],0.0035793229347014
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",41475,447,1.52 [1.13-2.03],0.0049109026145868
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",41226,198,2.18 [1.40-3.41],0.0006069002858524
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Other benign neoplasms of skin,51317,308,1.28 [0.88-1.87],0.1899271048057949
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",43186,2158,1.28 [1.11-1.48],0.0006098055670264
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",43305,2277,1.30 [1.13-1.49],0.0002293923593642
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,51090,687,2.49 [1.97-3.14],2.692158012975088e-14
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,47885,227,2.83 [1.88-4.25],6.162165904394416e-07
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,50545,142,3.59 [2.20-5.87],3.421371001430763e-07
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,50087,5830,2.03 [1.86-2.20],8.276949813559444e-62
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,48720,100,5.22 [3.08-8.85],7.962952291451601e-10
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,50841,101,4.69 [2.69-8.17],5.2788697211288534e-08
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,50702,3044,2.10 [1.88-2.36],2.082386802107385e-37
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,50700,3042,2.10 [1.87-2.35],3.2913389189734443e-37
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,47831,173,3.81 [2.43-5.96],5.193315588406953e-09
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,51020,2400,2.23 [1.96-2.53],8.22256643823146e-35
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,50970,230,2.53 [1.68-3.79],7.909871875958752e-06
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,50532,129,3.76 [2.30-6.13],1.174340449730161e-07
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,50524,121,1.90 [1.07-3.36],0.0282794093512225
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,51297,557,3.24 [2.52-4.15],1.7729755882273212e-20
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,51468,113,1.83 [1.01-3.33],0.0469369451652147
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",51203,463,3.54 [2.71-4.63],2.7502595795580607e-20
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,48835,215,4.27 [2.87-6.35],7.354196646383327e-13
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,39954,636,2.56 [2.01-3.27],4.0797512146184704e-14
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,48193,231,4.78 [3.52-6.49],1.3434431776122354e-23
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,48219,257,8.49 [6.44-11.20],4.946109678083158e-52
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,39428,110,2.71 [1.50-4.87],0.00090676153008
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,47991,135,1.93 [1.13-3.29],0.0154596188224638
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,46852,471,2.47 [1.87-3.27],2.572082163526896e-10
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",50729,1141,2.05 [1.71-2.47],1.8140264870517345e-14
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,50121,533,1.07 [0.80-1.44],0.639643329104566
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,49846,258,1.21 [0.80-1.82],0.3596387256754221
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,50975,3119,1.53 [1.36-1.72],5.729909776724327e-13
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,45020,3024,1.66 [1.48-1.87],4.160839548817477e-17
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",39452,134,1.78 [1.02-3.11],0.0414148530606924
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",47649,160,1.26 [0.75-2.14],0.3841975065451321
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,39883,565,1.92 [1.46-2.51],2.184699945504322e-06
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,39442,124,3.33 [1.93-5.73],1.4560368376378773e-05
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,46409,7091,1.28 [1.19-1.39],3.324197315764061e-10
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,39711,393,3.56 [2.63-4.82],2.3904658988382296e-16
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,40440,1122,2.36 [1.95-2.84],2.786714124724156e-19
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,51519,648,1.53 [1.19-1.97],0.0009443871959375
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,51143,272,1.33 [0.90-1.97],0.1550835517872141
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,39575,257,2.40 [1.62-3.55],1.124841662109552e-05
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",39440,122,5.03 [2.99-8.46],1.1084422912007635e-09
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,50601,3112,1.63 [1.45-1.83],2.8379060459843545e-16
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,39839,521,3.56 [2.74-4.61],9.655930738235393e-22
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,39916,598,3.58 [2.80-4.57],1.3375251524496916e-24
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",40587,1269,1.59 [1.32-1.90],6.228840841889778e-07
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,39559,241,1.64 [1.08-2.49],0.0211233052576383
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,51127,256,1.33 [0.88-1.99],0.1725291140820413
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,40529,1211,2.79 [2.33-3.34],6.610568575800198e-29
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,40286,968,2.92 [2.40-3.57],2.8809255641973717e-26
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,46521,140,1.96 [1.15-3.35],0.013163330251512
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,49319,10001,1.48 [1.39-1.58],1.0755776268272511e-32
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,47587,98,2.77 [1.47-5.25],0.0017136569367717
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,47602,113,1.86 [1.00-3.45],0.0509201898012022
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,51305,3894,1.15 [1.04-1.27],0.0071093801288137
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",51307,3889,1.15 [1.04-1.27],0.0075726757439148
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,47593,104,2.30 [1.23-4.31],0.0094297565155072
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,50993,2416,1.44 [1.26-1.65],6.336658476814747e-08
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",42502,3184,2.53 [2.27-2.83],5.160581451348476e-62
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,51655,456,3.47 [2.66-4.53],5.603028624774957e-20
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,49753,165,2.23 [1.38-3.59],0.0010183876446463
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,48785,208,1.72 [1.11-2.67],0.0156369627072364
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,48862,285,1.30 [0.88-1.92],0.1861818080314776
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",39655,337,1.69 [1.17-2.43],0.0047046704867529
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,47032,311,4.07 [2.93-5.68],9.71949780075091e-17
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,4238,174,2.01 [1.29-3.12],0.0019138622932641
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,4513,505,1.18 [0.91-1.54],0.2193727777734759
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,46850,129,5.51 [3.41-8.92],3.402351349935612e-12
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,4174,113,1.82 [1.06-3.14],0.0307428330973697
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,50396,3675,2.82 [2.56-3.11],9.957926483433457e-94
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,50294,706,1.47 [1.15-1.88],0.0019540967830374
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,47117,736,2.62 [2.09-3.28],4.116584568582021e-17
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,40867,1549,2.60 [2.23-3.05],5.955237447749309e-33
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",51451,481,1.48 [1.10-1.98],0.0089437582983124
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),49428,333,1.84 [1.31-2.57],0.000378191188157
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Angina pectoris,47189,2387,1.40 [1.23-1.60],4.904976595619255e-07
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Aortic aneurysm,49580,485,1.73 [1.31-2.30],0.0001391462056908
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,49211,116,3.21 [1.90-5.43],1.221238198409542e-05
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",49494,399,2.74 [2.04-3.67],2.0040175759465275e-11
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,32044,3822,1.64 [1.48-1.83],6.181562807278433e-20
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,AV-block,43544,870,1.50 [1.21-1.86],0.0002515163218733
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",51561,850,1.21 [0.97-1.51],0.0938241799403481
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Cardiac arrest,28602,380,2.80 [2.02-3.88],6.327450735092764e-10
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Cardiomyopathy,43013,339,1.64 [1.16-2.32],0.0049745616136775
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",42865,191,2.17 [1.39-3.39],0.0006475943691903
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,51676,102,2.93 [1.64-5.24],0.0002818215915378
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Conduction disorders,44779,2105,1.51 [1.32-1.74],6.411385672330184e-09
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,48936,4170,1.48 [1.34-1.64],4.4882020793349716e-15
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,45103,15154,1.45 [1.38-1.53],1.9489551054922866e-42
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,DVT of lower extremities,48901,521,1.43 [1.08-1.90],0.0125696467614018
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Endocarditis,42817,143,3.72 [2.29-6.03],1.0990730036837957e-07
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Heart failure, strict",51272,2205,1.95 [1.71-2.23],5.120979867447477e-23
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Hypertension,46937,13015,1.48 [1.40-1.57],3.8288976231385324e-41
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Hypertension, essential",46971,13049,1.47 [1.39-1.56],4.312787513697848e-40
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Hypertension, portal",51331,156,21.68 [16.05-29.28],1.970092178007729e-89
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",34273,351,3.10 [2.24-4.30],1.1692918588987163e-11
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,34194,272,2.48 [1.70-3.62],2.297134706740823e-06
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Hypotension,51392,2382,1.90 [1.67-2.17],1.3343742919630162e-22
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,49844,218,1.02 [0.65-1.59],0.9332705909028116
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",49278,4476,1.40 [1.27-1.54],3.982860950043911e-12
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",50933,1117,1.86 [1.55-2.25],6.757802606219584e-11
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Left bundle-branch block,43397,723,1.49 [1.17-1.89],0.0011211165417774
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,50721,1679,1.43 [1.22-1.67],6.272019685690547e-06
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",46220,1418,1.52 [1.29-1.80],9.938902543961022e-07
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",51490,305,1.23 [0.86-1.77],0.2616034112697878
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",51624,623,1.35 [1.05-1.75],0.0216069910550642
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Oesophageal varices,48487,107,23.65 [16.39-34.13],4.14816394351197e-64
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other aneurysm,49251,156,1.07 [0.64-1.81],0.7866252408489383
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other arrhythmias,43520,846,1.37 [1.10-1.72],0.0056594494961502
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,49296,201,2.59 [1.71-3.91],5.989033363629709e-06
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,49578,483,2.17 [1.65-2.86],3.807852072706931e-08
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,43031,357,1.25 [0.89-1.77],0.2026099730379062
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other disorders of veins,48575,195,1.57 [0.99-2.47],0.0528080826875855
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,48476,96,2.77 [1.51-5.10],0.0010515098112581
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,48802,125,1.96 [1.12-3.43],0.0182815867028648
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,48655,275,1.26 [0.86-1.86],0.2382740485257938
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,44755,2081,1.58 [1.37-1.81],1.8621415182108467e-10
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,49119,109,15.35 [10.43-22.60],1.3425143333250637e-43
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,50180,1085,2.11 [1.76-2.54],2.6720455432650544e-15
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,50446,690,2.91 [2.33-3.64],7.500278350374135e-21
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",49904,1227,1.89 [1.58-2.26],4.674128169555223e-12
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,28896,674,1.95 [1.51-2.52],2.507351640634027e-07
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Peripheral artery disease,49846,812,2.28 [1.85-2.81],1.1115751987158468e-14
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),49062,682,1.38 [1.08-1.77],0.0108739647944217
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Pulmonary embolism,50711,955,1.15 [0.94-1.42],0.1800643673688348
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,51542,1323,1.62 [1.36-1.93],7.27781535353757e-08
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Right bundle-branch block,43368,694,1.79 [1.41-2.28],2.2177110418246748e-06
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Secondary right heart disease,50435,679,2.81 [2.24-3.52],3.740229548428835e-19
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,49067,390,3.16 [2.36-4.25],1.8915297281731715e-14
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",50910,1284,1.75 [1.47-2.09],4.25971288326376e-10
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",50868,1362,1.73 [1.46-2.05],3.272534816326087e-10
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,49786,120,1.12 [0.62-2.02],0.7144369280101999
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,49256,162,1.24 [0.74-2.07],0.4072065658841947
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Transient ischemic attack,50285,469,1.52 [1.13-2.05],0.0056066195153843
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,49561,519,1.31 [0.99-1.74],0.0552343184729149
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Varicose veins,49226,846,1.22 [0.98-1.53],0.080662584832398
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,49122,170,1.51 [0.93-2.48],0.0986641441412019
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Venous thromboembolism,51226,1498,1.28 [1.08-1.51],0.0039041974266874
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",51436,719,5.02 [4.12-6.12],8.781114207624195e-58
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",45212,2854,1.56 [1.38-1.76],1.402681297591358e-12
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Any mental disorder,50380,8022,1.54 [1.43-1.65],3.854625050119892e-32
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",51342,848,4.33 [3.59-5.22],1.1968100829029558e-52
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",45534,3176,1.64 [1.46-1.84],3.079438722134156e-17
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",42539,181,1.76 [1.09-2.82],0.0196421167746519
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Smoking dependency,50618,2747,1.93 [1.73-2.14],8.917235233484494e-33
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",45624,3266,1.95 [1.75-2.16],1.4148055626700517e-35
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Vascular dementia,50651,251,1.99 [1.35-2.95],0.0005723280346176
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Alzheimer disease,51678,662,1.00 [0.77-1.30],0.9955046869444976
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",34811,115,1.51 [0.81-2.82],0.1907663101655135
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Bell's palsy,48121,161,2.49 [1.53-4.03],0.0002181602416875
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,48938,978,1.29 [1.04-1.58],0.0176422585009816
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Cerebral cysts,50861,468,2.09 [1.57-2.79],5.712030627968355e-07
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,51518,647,2.27 [1.79-2.89],1.826343770442989e-11
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,50674,101,1.22 [0.64-2.34],0.5426962725603109
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,51645,122,1.60 [0.90-2.84],0.1064685760541769
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",50544,151,2.00 [1.20-3.33],0.0079163001692381
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Epilepsy,48552,572,1.79 [1.37-2.34],1.7726544398086516e-05
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,50720,2740,1.45 [1.28-1.64],2.8271603018266035e-09
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,51593,1202,1.10 [0.91-1.33],0.3194598371941862
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Falls/tendency to fall,50483,5187,1.60 [1.46-1.75],1.7273883758134108e-24
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Generalized epilepsy,50912,105,3.16 [1.78-5.59],7.919939124041746e-05
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Hemiplegia,51377,506,2.37 [1.81-3.09],3.2759974059482673e-10
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Hydrocephalus,50517,124,1.84 [1.04-3.25],0.0355324674011464
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,51641,135,1.32 [0.76-2.32],0.3278455633195872
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,48106,146,0.76 [0.43-1.33],0.3411372491819671
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,48123,163,1.41 [0.86-2.32],0.1761242280114355
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Memory loss,50367,220,1.90 [1.24-2.90],0.0030475977023439
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Migraine,48696,716,1.52 [1.19-1.95],0.0008190602875854
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",51540,643,1.68 [1.30-2.18],7.41143896361411e-05
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Motor neuron disease,35010,274,1.62 [1.08-2.42],0.01933533072873
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,51346,208,1.17 [0.74-1.86],0.494917759030702
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",50344,2384,1.25 [1.09-1.43],0.0010976060308076
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Neurological diseases,48717,7542,1.30 [1.20-1.40],1.0676560728680338e-11
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,50978,405,1.86 [1.36-2.54],8.80123391282742e-05
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",48785,825,1.12 [0.89-1.41],0.3343881313432211
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",51528,591,2.37 [1.84-3.05],1.5538459701115422e-11
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,41103,1299,1.46 [1.21-1.75],5.429921970709914e-05
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,50541,148,1.29 [0.76-2.21],0.3451505791796806
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other disorders of nervous system,50671,278,1.57 [1.07-2.29],0.0202811709484401
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,50720,329,1.77 [1.24-2.52],0.0015796699974647
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other facial nerve disorders,48150,190,2.47 [1.59-3.85],6.293928772048435e-05
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other headache syndromes,48092,112,2.08 [1.15-3.76],0.0156381941675981
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other neurological diseases,51437,1044,1.71 [1.40-2.08],9.533111018686281e-08
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other sleep disorders,49100,1120,1.22 [1.01-1.48],0.0401269669162113
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Parkinson's disease,51632,850,0.98 [0.78-1.23],0.8806969844500177
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,50505,112,2.06 [1.12-3.79],0.0198625079071908
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Restless leg syndrome,51678,154,1.63 [0.97-2.74],0.0651816538248881
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Sleep apnoea,51194,963,1.12 [0.91-1.37],0.2742091885688259
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Small fibre neuropathy,51034,97,3.31 [1.82-6.02],9.11749547402262e-05
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,51651,329,1.31 [0.91-1.87],0.1441155334234616
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,48061,101,0.77 [0.39-1.50],0.4373285336805739
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,51678,669,1.04 [0.80-1.34],0.7776550466781531
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),50576,244,1.92 [1.29-2.87],0.0013497487211888
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,50535,199,1.27 [0.80-2.02],0.3185275489388803
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,50867,795,1.04 [0.82-1.32],0.7639586668098708
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,51330,466,2.71 [2.06-3.57],1.124899212125775e-12
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,49672,107,0.85 [0.44-1.62],0.6187875182282045
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,49678,113,1.24 [0.67-2.29],0.5007765984528278
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",51463,104,2.47 [1.35-4.50],0.0032747910679638
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,51162,292,0.91 [0.61-1.34],0.6209523695837422
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",4185,121,1.83 [1.08-3.09],0.0248312409796857
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,5073,204,1.65 [1.10-2.48],0.0151451508182031
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,50523,187,1.92 [1.21-3.04],0.0057882545489493
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,51245,2068,1.30 [1.13-1.50],0.0003180329584153
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",50950,1385,1.18 [0.99-1.41],0.0619946373018214
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,50011,446,1.50 [1.10-2.04],0.0110473555304134
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",51514,1442,0.95 [0.80-1.14],0.5950730479078588
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,51660,138,1.89 [1.11-3.24],0.019710794851718
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,51367,1295,0.95 [0.79-1.15],0.6260132335766273
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",51592,722,1.22 [0.95-1.56],0.1150318968852577
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,51492,357,1.26 [0.89-1.78],0.2004093825389193
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,49683,118,1.62 [0.90-2.91],0.1093940429688935
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,49698,133,1.20 [0.68-2.11],0.5224916314877891
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,49676,111,1.30 [0.69-2.44],0.4114080349215631
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,51491,1415,1.00 [0.84-1.19],0.9991933605479194
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,50446,370,1.01 [0.71-1.42],0.9755368959845186
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,50168,96,0.47 [0.24-0.93],0.0309964607835258
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,51063,193,1.79 [1.13-2.84],0.0129965227875746
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,51414,544,1.06 [0.79-1.40],0.7125157874918554
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,50457,385,1.02 [0.72-1.43],0.9186252730133052
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,51353,218,1.01 [0.64-1.59],0.9745520287158445
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,51019,943,1.09 [0.88-1.35],0.4318271316422962
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,50615,279,1.50 [1.02-2.20],0.0397148500146873
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,48476,4352,1.31 [1.18-1.44],1.7808007408560657e-07
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,51341,471,1.00 [0.74-1.36],0.9869292742387274
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,51638,308,2.17 [1.52-3.10],2.024798527214347e-05
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,50385,820,1.10 [0.87-1.38],0.4229375289274092
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,50996,126,1.72 [0.97-3.03],0.0626257774146735
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,51634,112,2.11 [1.17-3.81],0.0127319783025908
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,49733,168,1.47 [0.89-2.43],0.136683019325173
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,49864,299,1.00 [0.68-1.46],0.9867435379435512
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,49415,238,1.11 [0.73-1.71],0.622988224586924
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,50193,121,1.05 [0.58-1.93],0.8683788952817494
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",49302,125,0.70 [0.38-1.28],0.2437210808023697
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,50247,171,0.99 [0.59-1.65],0.955655596595276
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",50468,392,1.02 [0.73-1.43],0.8974260437324554
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,49821,256,1.12 [0.74-1.69],0.5798680261738541
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,49399,222,0.93 [0.59-1.45],0.7372405953304744
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,49348,171,1.11 [0.67-1.84],0.6867058875361172
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,47738,3614,1.30 [1.17-1.45],2.466808320462159e-06
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,49709,144,1.41 [0.82-2.44],0.2174438454341462
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,51158,822,1.58 [1.26-1.97],6.862455490347359e-05
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,50453,117,2.25 [1.28-3.96],0.0046859188681027
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),50678,342,1.87 [1.33-2.62],0.0003286394790345
PLA2G15,Phospholipase A2 group XV,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,51254,176,0.92 [0.56-1.53],0.7574327740236153
PLA2G15,Phospholipase A2 group XV,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,51590,238,1.22 [0.80-1.86],0.3529751603059908
PLA2G15,Phospholipase A2 group XV,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,51414,260,1.60 [1.07-2.37],0.0210024401493099
PLA2G15,Phospholipase A2 group XV,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,51196,118,2.05 [1.14-3.68],0.0160559977809057
PLA2G15,Phospholipase A2 group XV,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,51203,125,2.09 [1.19-3.68],0.0100421285186202
PLA2G15,Phospholipase A2 group XV,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,51482,1789,1.47 [1.26-1.71],7.912206803735075e-07
PLA2G15,Phospholipase A2 group XV,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,50972,1279,1.59 [1.32-1.90],5.090810329996083e-07
PLA2G15,Phospholipase A2 group XV,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,49946,253,0.91 [0.60-1.39],0.6700366971485701
PLA2G15,Phospholipase A2 group XV,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,49866,173,1.89 [1.17-3.05],0.0096772101218358
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Acute pharyngitis,51190,149,2.31 [1.40-3.83],0.0011321793229901
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,51467,426,1.61 [1.18-2.19],0.0025554469772281
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,51168,127,2.10 [1.21-3.64],0.0081644522184423
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,All influenza,47632,238,2.67 [1.79-3.99],1.6357893335381785e-06
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),47627,233,2.64 [1.76-3.97],2.7489109284511373e-06
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Allergic asthma (mode),35396,231,0.95 [0.61-1.49],0.8254215115771708
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Allergic rhinitis,51414,559,1.07 [0.81-1.41],0.6517267056665199
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",38148,3523,1.35 [1.21-1.51],1.939974836751074e-07
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",38637,3472,1.33 [1.19-1.49],7.390436560769215e-07
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),50870,278,1.92 [1.33-2.78],0.0005361042213994
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",47560,166,1.80 [1.11-2.94],0.0176320052899247
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Bronchiectasis,44808,710,2.02 [1.59-2.57],7.576361590132474e-09
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",44216,118,3.17 [1.84-5.47],3.36974289945352e-05
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,49659,5561,1.47 [1.34-1.60],5.280967935299526e-18
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",48938,142,0.75 [0.43-1.31],0.308029977314078
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Chronic sinusitis,49104,308,1.19 [0.82-1.72],0.3727259820550102
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",51281,2377,1.98 [1.75-2.24],1.0639921053432355e-26
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Deviated nasal septum,49010,214,0.80 [0.51-1.25],0.3242964263344077
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,47552,10527,1.53 [1.43-1.63],3.477416762259996e-39
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",49519,723,1.20 [0.94-1.52],0.1456947477433534
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Early onset COPD,49527,623,2.63 [2.12-3.26],2.004589913914779e-18
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Emphysema,44723,625,2.60 [2.06-3.29],1.4444595003109996e-15
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,49090,571,2.81 [2.18-3.61],1.0078719028714326e-15
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Influenza and pneumonia,51232,3838,2.02 [1.83-2.24],1.234725248565562e-42
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Interstitial lung disease,49160,641,2.84 [2.24-3.60],7.458715313017843e-18
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Later onset COPD,49687,1754,1.73 [1.49-2.01],6.665802818298969e-13
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,51654,653,1.91 [1.50-2.44],1.827001072075096e-07
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Nasal polyp,49010,214,0.90 [0.57-1.40],0.6317963536369333
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,51177,1943,1.87 [1.62-2.16],5.715481646012103e-18
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other diseases of pleura,51214,3994,1.95 [1.76-2.15],5.127511192584819e-40
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,50462,1666,1.14 [0.97-1.34],0.1101240813798533
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other pleural conditions,47323,103,4.76 [2.74-8.26],2.926734394245121e-08
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,51507,800,2.59 [2.09-3.20],1.4963761098235077e-18
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,51468,2602,1.81 [1.60-2.04],2.656591366034871e-21
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Pleural effusion,49210,1990,2.27 [1.98-2.60],1.885548623711724e-31
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Pleural plaque,47532,312,2.30 [1.63-3.26],2.587778043589404e-06
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",50730,3336,2.01 [1.81-2.24],7.271829796091376e-37
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,51527,526,1.86 [1.42-2.45],7.795322694788992e-06
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Pneumothorax,47456,236,1.86 [1.23-2.80],0.0033181956424098
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Pollen allergy,51632,477,1.06 [0.79-1.44],0.6864910437454996
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Pulmonary oedema,50839,132,2.62 [1.56-4.41],0.0002844128394861
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Respiratory insufficiency,35270,105,2.97 [1.64-5.40],0.0003466101315132
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,51133,1899,1.91 [1.65-2.20],1.3488170091915893e-18
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,49357,561,1.08 [0.81-1.43],0.5946889877345112
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Viral pneumonia,47896,502,1.82 [1.37-2.42],3.4494287294877096e-05
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",50901,413,1.80 [1.32-2.45],0.0001895074870023
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,23823,221,1.98 [1.27-3.08],0.0024121159448274
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,36492,126,2.15 [1.25-3.70],0.0057359179564897
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Acute appendicitis,51356,288,1.28 [0.87-1.88],0.2176522038713058
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Acute gastritis,38878,183,2.53 [1.59-4.03],9.232565806617612e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Acute pancreatitis,47981,370,2.75 [2.01-3.76],2.719931072905753e-10
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Acute peritonitis,50728,188,3.33 [2.18-5.10],2.5891101291079632e-08
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Alcoholic liver disease,49895,151,18.75 [13.78-25.51],8.687235234493165e-78
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Barrett oesophagus,39565,870,2.14 [1.72-2.65],5.910030934702273e-12
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",47812,201,2.92 [1.92-4.45],5.365728890371783e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",50832,201,2.81 [1.84-4.28],1.7437252547075936e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Cholecystitis,48015,404,1.94 [1.42-2.65],2.930365224309925e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Cholelithiasis,49607,1996,1.98 [1.72-2.28],2.4856418193011792e-21
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Chronic gastritis,39305,610,2.00 [1.54-2.59],2.0271936735456853e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Chronic pancreatitis,47711,100,4.18 [2.42-7.22],2.884057369219345e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",51384,209,19.87 [15.24-25.89],2.5166195518714762e-108
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Coeliac disease,48457,248,6.16 [4.34-8.75],3.4488080572440874e-24
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Collagenous colitis,48304,161,1.60 [0.96-2.68],0.0730016301285758
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,51373,371,1.29 [0.93-1.81],0.1301462481536581
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Constipation,51167,3344,1.49 [1.33-1.67],2.657151221769018e-12
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Crohn disease,48329,186,3.30 [2.13-5.12],8.600812559182879e-08
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",50964,136,2.82 [1.68-4.74],8.996598545705062e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Crohn's disease NAS,48318,175,3.28 [2.08-5.15],2.711424386703172e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Dental caries,50187,459,1.81 [1.35-2.42],6.410480011025871e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,46391,4474,1.44 [1.31-1.59],1.6784735157735865e-13
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of appendix,51429,361,1.19 [0.84-1.69],0.3218753029517253
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of liver,51434,1690,4.18 [3.64-4.81],1.1600299918719001e-89
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",47359,8664,1.54 [1.43-1.65],2.755273453875645e-33
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",50836,1108,1.68 [1.39-2.04],8.542141677209138e-08
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of peritoneum,51505,965,2.18 [1.78-2.67],2.83388925066878e-14
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,49954,226,1.50 [0.98-2.29],0.0624986144400652
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of salivary glands,49659,129,1.06 [0.60-1.87],0.8430205187456143
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of the digestive system,51056,2847,1.77 [1.58-2.00],3.926711714986979e-21
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of tongue,49690,221,1.49 [0.96-2.29],0.0738632867795612
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",50420,2809,2.05 [1.83-2.31],5.044437697880665e-33
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,42678,6312,1.27 [1.17-1.38],1.0372366938439093e-08
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Duodenal ulcer,39094,399,2.52 [1.85-3.43],4.575310703576435e-09
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",51515,321,2.48 [1.78-3.46],8.319882934037229e-08
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,51500,110,2.15 [1.17-3.94],0.013434403585193
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,49997,253,16.18 [12.50-20.95],4.116967808158813e-99
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,36659,293,1.31 [0.89-1.92],0.1646501961835124
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Functional dyspepsia,39788,1093,1.21 [0.99-1.49],0.0605623754285849
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastric ulcer,39412,717,2.08 [1.65-2.64],9.559585042007276e-10
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,43695,5000,1.48 [1.35-1.63],1.265757237690158e-16
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,39767,1072,2.06 [1.70-2.50],1.6793990465761288e-13
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,39989,16582,1.33 [1.26-1.40],2.8853876022003768e-27
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,GI-bleeding,50542,2333,1.55 [1.36-1.77],8.315757506336668e-11
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,49837,109,2.38 [1.33-4.27],0.0034522546782378
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,38321,2521,1.30 [1.14-1.49],9.467778387383966e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",49873,129,7.86 [5.09-12.15],1.7158685955080562e-20
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Hernia,48418,6501,1.27 [1.17-1.37],1.1855848641073926e-08
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Impacted teeth,51513,102,2.00 [1.06-3.78],0.0320311728842843
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Impaction of intestines,36478,112,1.94 [1.07-3.54],0.0297726197930634
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Inguinal hernia,43716,1799,0.92 [0.78-1.07],0.276692188564325
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",42124,207,0.71 [0.45-1.13],0.1459818401135841
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,36559,193,2.12 [1.34-3.35],0.0012864333563141
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Intestinal malabsorption,48496,287,5.45 [3.90-7.60],2.183493221995756e-23
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,37474,1108,1.50 [1.23-1.84],6.485492646844371e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,51622,740,4.67 [3.80-5.74],6.125707773224989e-49
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,49654,1511,1.90 [1.61-2.23],1.6494610150065115e-14
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,50152,2009,1.76 [1.52-2.03],1.1090225471263847e-14
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Oesophageal obstruction,39070,375,2.44 [1.77-3.36],6.065182146484438e-08
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Oesophagitis,39904,1209,1.97 [1.64-2.37],3.488435271228465e-13
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,51580,273,1.20 [0.81-1.79],0.3574510660255399
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,42055,138,1.71 [1.00-2.95],0.0517540610074551
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,39094,2728,1.43 [1.26-1.62],2.5399011977517885e-08
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,48174,563,1.95 [1.50-2.54],7.591616390808917e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,47921,310,1.70 [1.18-2.45],0.0043542464675116
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of intestine,39861,3495,1.47 [1.31-1.64],8.520296208827301e-12
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of intestines,47656,11290,1.34 [1.26-1.43],1.41130452631814e-20
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,49647,417,1.17 [0.85-1.61],0.3435232721169658
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of liver,51129,1385,4.07 [3.48-4.75],3.331928084765305e-70
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,40021,1326,2.12 [1.78-2.52],4.765344089588903e-17
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of pancreas,47914,303,2.53 [1.79-3.57],1.6161216484724205e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,51368,828,2.02 [1.62-2.51],3.6340305737954935e-10
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,40602,1907,2.54 [2.20-2.94],1.6960073694543827e-36
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,50571,2362,1.54 [1.35-1.76],1.1555354948185962e-10
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,50104,376,1.58 [1.14-2.20],0.0060804114522209
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,39805,3439,1.58 [1.41-1.76],7.023263646519347e-16
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),42731,4036,1.88 [1.70-2.08],2.257420574543562e-34
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,49943,199,9.52 [6.71-13.51],1.965633807904133e-36
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,49907,1764,1.82 [1.56-2.12],1.2095389798144443e-14
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",37053,687,1.66 [1.29-2.12],5.903322451667116e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,51481,129,2.10 [1.20-3.68],0.0097723635217697
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,37347,981,1.62 [1.32-2.00],4.466922398953539e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",48511,302,2.44 [1.71-3.47],7.921337341636566e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Recurring oral aphthae,51657,114,3.10 [1.77-5.43],8.058407067167683e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,49739,236,2.75 [1.85-4.08],5.684952115525625e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Toxic colitis,48255,112,2.42 [1.34-4.39],0.0035834001402068
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,39235,540,2.24 [1.71-2.94],4.3806957831546235e-09
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Ulcerative colitis,48465,322,1.62 [1.13-2.33],0.0091262325667851
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",48410,267,1.52 [1.02-2.26],0.0407100586056924
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Umbilical hernia,42458,541,1.32 [1.00-1.74],0.0476863804192137
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,36716,350,2.10 [1.50-2.93],1.4817795297155016e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Ventral hernia,42434,517,1.66 [1.26-2.20],0.0003582143535085
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Volvulus,36528,162,1.25 [0.74-2.11],0.4048662332371614
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,51514,594,1.31 [1.00-1.71],0.053981376880875
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,51032,143,4.83 [3.03-7.70],3.718725273899801e-11
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,47576,320,1.24 [0.85-1.80],0.2619096665054298
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,50404,1413,1.63 [1.38-1.93],9.873880207462105e-09
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",49340,349,1.59 [1.14-2.23],0.0070221763083512
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,48069,813,2.41 [1.95-2.98],2.5661297634061867e-16
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,51063,549,1.86 [1.42-2.43],6.794544750760253e-06
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,51477,963,1.94 [1.58-2.37],1.5226627727297218e-10
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,50611,97,3.32 [1.81-6.11],0.0001136593607114
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,48561,6411,1.45 [1.34-1.57],3.691512728512346e-19
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,50769,898,1.03 [0.83-1.29],0.7754495999785987
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,50506,635,0.93 [0.71-1.20],0.5623969951435184
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,50894,1903,1.53 [1.32-1.77],8.43012329036695e-09
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",51645,109,2.16 [1.17-4.00],0.0137804353418639
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,47371,115,4.19 [2.44-7.18],1.8601961201521085e-07
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,49974,103,1.43 [0.76-2.69],0.2687119561733976
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,51044,530,1.77 [1.35-2.34],4.667110026445891e-05
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,48164,908,1.27 [1.02-1.58],0.0345131057930634
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,47385,129,1.17 [0.65-2.08],0.6008291230021547
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,51505,168,1.25 [0.76-2.05],0.3806390104939261
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,49369,378,1.53 [1.11-2.13],0.0101616293842522
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,51276,387,1.95 [1.42-2.68],3.8058984667819606e-05
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,50644,130,1.99 [1.16-3.42],0.0126320864542883
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,47390,134,0.74 [0.41-1.33],0.3125784577572282
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,50521,3265,1.49 [1.33-1.67],3.33358807959257e-12
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",48241,985,1.34 [1.09-1.66],0.0056920524993266
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,47393,137,1.19 [0.68-2.09],0.5366664470918652
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,51501,612,2.18 [1.70-2.81],1.206048362614526e-09
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,50654,140,2.51 [1.50-4.19],0.0004566598897567
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,51390,501,2.23 [1.69-2.94],1.1798862783437036e-08
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,51570,650,1.30 [1.01-1.69],0.0455300712872112
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,47506,250,1.10 [0.72-1.68],0.6708596183156963
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,47795,539,0.87 [0.65-1.16],0.3418540063814761
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,51549,629,1.30 [1.00-1.69],0.0535568386111759
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",47736,480,2.54 [1.94-3.34],1.6108114613812666e-11
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,51617,280,1.22 [0.83-1.79],0.3219220412429813
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,44338,220,2.07 [1.35-3.17],0.0008730888868121
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,47038,11279,1.21 [1.14-1.29],2.762275330943273e-09
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,44206,8447,1.15 [1.07-1.24],0.0001274078059135
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,44269,151,1.04 [0.60-1.78],0.8936596916090048
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,44799,304,1.76 [1.22-2.54],0.0025799769849778
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,44854,359,1.69 [1.20-2.38],0.0028528044993267
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,51180,184,1.13 [0.70-1.83],0.6232830272168606
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",44693,198,2.37 [1.51-3.72],0.0001667323500566
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,38025,2266,1.06 [0.92-1.23],0.3838791385677109
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",51407,371,0.96 [0.68-1.35],0.8052960163501084
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,45392,897,1.33 [1.07-1.67],0.0113009917892757
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,43691,14539,1.23 [1.16-1.30],3.044604817458637e-13
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,47714,232,1.61 [1.05-2.46],0.0287314383541573
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,44421,303,1.65 [1.14-2.37],0.0073261103956662
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,45249,1131,1.18 [0.97-1.44],0.0979594916826615
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,49821,5326,1.38 [1.26-1.50],2.757975721003746e-12
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,44660,542,1.36 [1.03-1.80],0.0317464851510562
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,44563,445,1.66 [1.22-2.27],0.0012895980757623
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,44385,267,1.07 [0.71-1.62],0.7428623166765973
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,50388,139,1.21 [0.69-2.14],0.504224259370482
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,39139,3380,1.10 [0.98-1.23],0.1012697066031331
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,36975,1216,1.53 [1.28-1.84],4.880661213160219e-06
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",51525,1199,1.47 [1.22-1.76],4.09156765835291e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,35910,151,1.03 [0.59-1.80],0.9131915512151948
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),36414,655,0.82 [0.63-1.07],0.144706413646641
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,44723,605,1.17 [0.90-1.53],0.2461270020229937
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,37039,1280,0.97 [0.81-1.17],0.7703753710778171
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,44605,110,3.04 [1.68-5.51],0.0002356478003592
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,45757,1262,1.46 [1.21-1.75],5.525505944391419e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,45103,608,1.16 [0.89-1.52],0.2786759309513446
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,36956,1197,0.94 [0.77-1.14],0.5223189679716276
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,44279,161,1.83 [1.10-3.03],0.0192532233492313
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",44242,124,1.45 [0.81-2.61],0.2100151170610792
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,47626,144,4.11 [2.57-6.56],3.689518818961783e-09
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,50907,3425,1.91 [1.71-2.13],1.9110472736589963e-30
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,49723,2241,2.05 [1.79-2.35],1.0798081114317522e-24
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",51393,903,2.00 [1.62-2.47],8.214091472105497e-11
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,40732,4973,1.32 [1.20-1.45],8.992964567015253e-09
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,35885,126,1.01 [0.55-1.83],0.9829778323371748
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,44302,184,1.20 [0.74-1.94],0.469747465466556
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,35857,98,1.55 [0.80-3.00],0.1951577246344792
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),36010,251,1.09 [0.71-1.68],0.6955963326055036
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,47967,485,1.48 [1.10-1.99],0.0093804623075535
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,48242,760,2.21 [1.74-2.79],5.2614624975106284e-11
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,51612,200,1.80 [1.15-2.83],0.0101078532969263
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",48104,3609,1.41 [1.26-1.57],7.67422296745089e-10
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,44319,201,1.45 [0.91-2.31],0.1181524506805846
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),36035,276,0.90 [0.60-1.36],0.6249045022155455
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,45944,1449,1.43 [1.21-1.70],3.98392389080355e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,40063,4304,1.17 [1.06-1.30],0.0020259302965322
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,50438,189,1.52 [0.95-2.45],0.083050520305417
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,51641,136,5.07 [3.15-8.15],2.037588409005215e-11
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,44280,162,1.06 [0.63-1.77],0.8300158411388294
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",46619,2501,1.47 [1.29-1.67],6.4212872358909406e-09
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,44297,179,1.44 [0.89-2.34],0.1361231855925563
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,38990,3231,1.42 [1.26-1.59],3.299734355417461e-09
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,47708,226,1.51 [0.98-2.34],0.0609363307683729
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,44227,109,1.23 [0.65-2.33],0.5334769040944372
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,44812,317,1.32 [0.91-1.92],0.1415652619134498
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,45227,1109,1.62 [1.34-1.97],7.864447856472992e-07
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,50957,708,2.03 [1.59-2.59],1.0627877284458974e-08
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,45638,1143,1.75 [1.44-2.11],9.610028395144052e-09
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,51417,877,2.10 [1.70-2.59],7.049750546709302e-12
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,51635,106,1.76 [0.94-3.28],0.0760895137022594
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,44495,377,1.32 [0.94-1.86],0.1077872580131023
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,40907,1511,1.70 [1.44-2.01],3.9446176398353757e-10
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,45280,1162,1.44 [1.19-1.74],0.0001796616622098
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],44571,453,1.51 [1.11-2.04],0.0081319154959223
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",35866,107,2.45 [1.32-4.54],0.0043935238881578
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,40719,4960,1.47 [1.34-1.61],3.2371734528197936e-16
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,37068,1309,1.29 [1.07-1.55],0.0073244622921403
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,50713,464,1.24 [0.91-1.69],0.1761556303077976
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",51544,132,2.19 [1.27-3.79],0.005008813806726
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",47350,100,0.95 [0.49-1.83],0.8793761448820689
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,35898,139,5.37 [3.32-8.68],7.364678588128246e-12
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,44699,204,1.10 [0.69-1.76],0.67415859393137
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,36674,915,2.10 [1.70-2.59],7.80051459963614e-12
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,44734,616,1.08 [0.83-1.41],0.561225399010636
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,45004,509,1.46 [1.09-1.95],0.010767676477464
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,44877,382,1.44 [1.02-2.03],0.0361372763605425
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,40411,116,1.47 [0.79-2.73],0.2189881794268438
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",51643,114,1.77 [0.97-3.22],0.0629708068344819
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,45297,1179,1.25 [1.03-1.52],0.0210727850260896
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],50434,185,5.56 [3.63-8.52],3.270166123215139e-15
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,49265,5147,1.28 [1.16-1.40],1.7514593652787525e-07
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",44381,263,0.91 [0.60-1.37],0.6360408569101204
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,45579,1084,1.51 [1.24-1.84],4.095997065011241e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,48859,470,1.28 [0.94-1.73],0.1144445655502482
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,44912,417,1.08 [0.78-1.50],0.6413717545494827
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,47607,3112,1.46 [1.30-1.65],1.3237427615930986e-10
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,46541,2046,1.45 [1.25-1.67],4.6484136263850274e-07
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],44223,105,1.08 [0.57-2.06],0.8047846411383497
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,50518,269,5.00 [3.54-7.07],7.442707311188304e-20
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,44443,325,1.05 [0.73-1.53],0.7813208588424857
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,44269,151,0.98 [0.56-1.69],0.934621819079671
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),35875,116,1.78 [0.97-3.25],0.0618971941657627
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Acute renal failure,49572,3151,2.36 [2.12-2.63],5.045571703877391e-54
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20864,103,1.27 [0.65-2.47],0.4794794327228807
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27175,112,1.35 [0.71-2.55],0.359583559567405
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,51039,644,1.43 [1.11-1.84],0.0051236834546375
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,50563,168,1.11 [0.67-1.82],0.6917264320430697
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,49490,3069,1.82 [1.63-2.05],7.030198790985961e-25
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,51249,168,2.21 [1.38-3.54],0.0010150396982742
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,51181,603,1.46 [1.13-1.90],0.0041625851183351
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Cystitis,45504,471,1.29 [0.95-1.74],0.1045642143160144
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Dialysis,46578,157,2.76 [1.71-4.45],2.964883428275633e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,22505,3316,0.98 [0.88-1.10],0.7161713079994607
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27406,343,1.37 [0.95-1.97],0.0878265335792032
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Endometriosis,20944,183,1.03 [0.62-1.70],0.9153749047066266
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21160,399,1.28 [0.91-1.80],0.1489951295147872
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21790,1029,1.21 [0.98-1.50],0.0706363308592653
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,43112,10750,1.39 [1.31-1.48],7.118047194217699e-25
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,51250,169,3.85 [2.49-5.97],1.539854737078936e-09
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Hydrocele,19394,205,0.68 [0.43-1.06],0.0909526617205356
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,46404,586,1.31 [1.00-1.71],0.0525295282641759
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21799,2610,1.01 [0.89-1.14],0.9249041641654115
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27330,405,1.32 [0.95-1.83],0.1030547165970324
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19423,234,0.69 [0.45-1.06],0.0913244462946328
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Irregular menses,27411,131,1.50 [0.83-2.70],0.1763930494925627
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21068,307,1.60 [1.09-2.35],0.0163425944204106
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,45191,158,1.40 [0.83-2.34],0.2045818830053934
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,23262,2501,1.19 [1.04-1.36],0.0108163857980458
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,19295,106,1.42 [0.78-2.60],0.2544067533809307
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20906,145,1.17 [0.67-2.06],0.5815930120893489
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",51652,130,1.48 [0.84-2.60],0.1770588068264472
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",51662,134,1.19 [0.68-2.09],0.5453503047313619
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,49585,4552,1.47 [1.34-1.62],2.9690977435891125e-15
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,46475,1442,1.09 [0.92-1.30],0.3259231998375783
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27183,120,1.18 [0.64-2.19],0.6006058840611256
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,51538,960,1.59 [1.30-1.96],8.174618560810488e-06
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19498,309,0.97 [0.67-1.40],0.8723677119918132
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19466,277,1.15 [0.79-1.69],0.4654767285176789
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,19415,226,0.73 [0.47-1.12],0.1508285286927293
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,51597,141,1.55 [0.90-2.67],0.1168148341904882
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,48538,3505,1.73 [1.55-1.93],2.890477148019906e-23
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27136,211,1.15 [0.73-1.83],0.5497666221241762
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20920,159,0.99 [0.58-1.69],0.9618235278300404
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21140,379,0.94 [0.66-1.32],0.71231305537904
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20874,113,2.60 [1.43-4.73],0.0017734852373136
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20971,210,1.27 [0.80-2.02],0.3122678030276692
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,46503,685,1.30 [1.01-1.67],0.0395825635388576
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,50897,319,1.58 [1.11-2.25],0.011569769526372
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,21075,314,0.86 [0.58-1.26],0.4374011808213295
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20869,108,1.41 [0.74-2.70],0.2982861336467748
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21416,655,1.05 [0.80-1.36],0.7372088490901718
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,20925,164,1.00 [0.59-1.71],0.9885864562628172
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21365,604,1.00 [0.76-1.32],0.9968250469614774
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,51176,95,2.14 [1.14-4.03],0.0182980132876427
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19453,264,1.32 [0.90-1.95],0.1570736114092594
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,51176,5358,1.92 [1.77-2.10],2.516314273852468e-50
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",46062,244,2.61 [1.75-3.91],2.7715115665990326e-06
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,46685,264,3.07 [2.14-4.42],1.513182031377555e-09
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,50508,113,1.82 [1.02-3.27],0.0440335030245759
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Urethral stricture,45477,444,1.52 [1.12-2.06],0.0071965026359668
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Urolithiasis,51192,797,1.38 [1.10-1.73],0.0050275585046037
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20904,143,1.76 [1.02-3.06],0.0438291310476439
